Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
3.300
-0.020 (-0.60%)
At close: Jun 27, 2025, 4:00 PM
3.270
-0.030 (-0.91%)
After-hours: Jun 27, 2025, 5:25 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $565.77 million as of June 27, 2025. Its market cap has decreased by -37.23% in one year.
Market Cap
565.77M
Enterprise Value
-97.43M
1-Year Change
-37.23%
Ranking
Category
Stock Price
$3.30
Market Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has decreased from $3.03B to $565.77M, a decrease of -81.36%. That is a compound annual growth rate of -28.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 576.06M | -16.47% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | 3.73B | 22.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.28B |
| Johnson & Johnson | 366.40B |
| AbbVie | 327.47B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.97B |
| Abbott Laboratories | 239.05B |
| Novartis AG | 231.01B |
| AstraZeneca | 216.45B |